Logo

The US FDA Grants Approval to Boston Scientific’s Farapulse Pulsed Field Ablation (PFA) System for Atrial Fibrillation (AF)

Share this
Boston Scientific

The US FDA Grants Approval to Boston Scientific’s Farapulse Pulsed Field Ablation (PFA) System for Atrial Fibrillation (AF)

Shots:

  • The Farapulse PFA System is approved to extract pulmonary veins for treating drug-refractory, recurrent, symptomatic, paroxysmal AF based on the 12mos. data from (ADVENT) study of the system vs SoC ablation
  • The device demonstrated shorter ablation time and a fast-learning curve for physicians. The RWE from the MANIFEST-17K registry showed its real-world safety without permanent phrenic nerve palsy, pulmonary vein stenosis or esophageal injury
  • The system includes Farawave Ablation Catheter, Farastar Ablation Generator & Faradrive Steerable Sheath, accompanied by VersaCross Connect Access Solution, for safe access to the left side of the heart. It utilizes tissue-selective, non-thermal electric fields for heart tissue ablation thus preventing damage to surrounding tissues

Ref: Boston Scientific | Image: Boston Scientific

Related News:- Boston Scientific Commences (AVANT GUARD) Study of Farapulse Pulsed Field Ablation System as a 1L Treatment for Persistent Atrial Fibrillation (AF)

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions